BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk B, Chirlaque M, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R, Hackl M, Zielonke N, Van Eycken E, Henau K, Valerianova Z, Dimitrova N, Sekerija M, Dušek L, Zvolský M, Storm H, Engholm G, Mägi M, Aareleid T, Malila N, Seppä K, Velten M, Guizard A, Faivre J, Woronoff A, Tretarre B, Bossard N, Uhry Z, Colonna M, Molinié F, Bara S, Schvartz C, Lapôtre-ledoux B, Grosclaude P, Stabenow R, Luttmann S, Eberle A, Brenner H, Nennecke A, Engel J, Schubert-fritschle G, Heidrich J, Holleczek B, Katalinic A, Jónasson J, Tryggvadóttir L, Comber H, Mazzoleni G, Bulatko A, Buzzoni C, Giacomin A, Sutera Sardo A, Mazzei A, Ferretti S, Barchielli A, Caldarella A, Gatta G, Sant M, Amash H, Amati C, Baili P, Berrino F, Bonfarnuzzo S, Botta L, Capocaccia R, Di Salvo F, Foschi R, Margutti C, Meneghini E, Minicozzi P, Trama A, Serraino D, Zucchetto A, De Angelis R, Caldora M, Carrani E, Francisci S, Mallone S, Pierannunzio D, Roazzi P, Rossi S, Santaquilani M, Tavilla A, Pannozzo F, Busco S, Filiberti R, Vercelli M, Ricci P, Autelitano M, Spagnoli G, Cirilli C, Fusco M, Vitale M, Usala M, Vitale F, Ravazzolo B, Michiara M, Tumino R, Mangone L, Vicentini M, Falcini F, Iannelli A, Sechi O, Cesaraccio R, Piffer S, Madeddu A, Tisano F, Maspero S, Fanetti A, Zanetti R, Rosso S, Candela P, Scuderi T, Stracci F, Rocca A, Tagliabue G, Contiero P, Rugge M, Tognazzo S, Pildava S, Smailyte G, Calleja N, Agius D, Johannesen T, Rachtan J, Góźdź S, Mężyk R, Błaszczyk J, Bębenek M, Bielska-lasota M, Forjaz de Lacerda G, Bento M, Castro C, Miranda A, Mayer-da-silva A, Safaei Diba C, Primic-zakelj M, Errezola M, Bidaurrazaga J, Díaz García J, Marcos-navarro A, Marcos-gragera R, Izquierdo Font A, Sanchez M, Molina E, Navarro C, Chirlaque M, Moreno-iribas C, Ardanaz E, Galceran J, Carulla M, Lambe M, Khan S, Mousavi M, Bouchardy C, Usel M, Ess S, Frick H, Lorez M, Ess S, Herrmann C, Bordoni A, Spitale A, Konzelmann I, Visser O, Ho V, Otter R, Coleman M, Allemani C, Rachet B, Rashbass J, Broggio J, Verne J, Gavin A, Donnelly C, Brewster D, Huws D, White C. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. European Journal of Cancer 2017;77:140-52. [DOI: 10.1016/j.ejca.2017.02.023] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019;30:1856-83. [PMID: 31549998 DOI: 10.1093/annonc/mdz400] [Cited by in Crossref: 115] [Cited by in F6Publishing: 105] [Article Influence: 57.5] [Reference Citation Analysis]
2 Solymosi T, Hegedüs L, Bodor M, Nagy EV. EU-TIRADS-Based Omission of Fine-Needle Aspiration and Cytology from Thyroid Nodules Overlooks a Substantial Number of Follicular Thyroid Cancers. Int J Endocrinol 2021;2021:9924041. [PMID: 34616450 DOI: 10.1155/2021/9924041] [Reference Citation Analysis]
3 Afshar N, English DR, Thursfield V, Mitchell PL, Te Marvelde L, Farrugia H, Giles GG, Milne RL. Differences in cancer survival by sex: a population-based study using cancer registry data. Cancer Causes Control 2018;29:1059-69. [PMID: 30194549 DOI: 10.1007/s10552-018-1079-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
4 Li M, Delafosse P, Meheus F, Borson-Chazot F, Lifante JC, Simon R, Groclaude P, Combes JD, Dal Maso L, Polazzi S, Duclos A, Colonna M, Vaccarella S; Thyroid Cancer Group FRANCIM. Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiol 2021;75:102051. [PMID: 34743057 DOI: 10.1016/j.canep.2021.102051] [Reference Citation Analysis]
5 Jeon MJ, Kim WG, Kim TH, Kim HK, Kim BH, Yi HS, Kim ES, Kim H, Kim YN, Kim EH, Kim TY, Kim SW, Kang HC, Chung JH, Shong YK, Kim WB; Korean Thyroid Cancer Study Group. Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study. Endocrinol Metab (Seoul) 2017;32:434-41. [PMID: 29199400 DOI: 10.3803/EnM.2017.32.4.434] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
6 Moustafa AE, Robert Green F, Fraser S, Vaidyanathan S, Moor JW. The use of ultrasound-guided preoperative colloidal charcoal injection in the surgical management of recurrent differentiated thyroid cancer-A pilot study in 3 patients. Clin Otolaryngol 2021;46:421-4. [PMID: 33112471 DOI: 10.1111/coa.13663] [Reference Citation Analysis]
7 Teodoriu L, Ungureanu MC, Leustean L, Preda C, Ciobanu D, Grierosu I, Matei M, Iacob R, Stefanescu C. Updated Incidence of Thyroid Cancer in the North East Region of Romania after 35 Years of Chernobyl Fallout. Is There a Link between? Diagnostics (Basel) 2021;11:907. [PMID: 34069605 DOI: 10.3390/diagnostics11050907] [Reference Citation Analysis]
8 Wang X, Huang S, Li X, Jiang D, Yu H, Wu Q, Gao C, Wu Z. A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma. PLoS One 2018;13:e0200290. [PMID: 30005075 DOI: 10.1371/journal.pone.0200290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Hegedűs L, Rittler D, Garay T, Stockhammer P, Kovács I, Döme B, Theurer S, Hager T, Herold T, Kalbourtzis S, Bankfalvi A, Schmid KW, Führer D, Aigner C, Hegedűs B. HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line. Pathol Oncol Res 2020;26:2523-35. [PMID: 32591993 DOI: 10.1007/s12253-020-00834-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Locati LD, Piovesan A, Durante C, Bregni M, Castagna MG, Zovato S, Giusti M, Ibrahim T, Puxeddu E, Fedele G, Pellegriti G, Rinaldi G, Giuffrida D, Verderame F, Bertolini F, Bergamini C, Nervo A, Grani G, Rizzati S, Morelli S, Puliafito I, Elisei R. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. Eur J Cancer. 2019;118:35-40. [PMID: 31299580 DOI: 10.1016/j.ejca.2019.05.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
11 Meyer HJ, Schob S, Höhn AK, Surov A. MRI Texture Analysis Reflects Histopathology Parameters in Thyroid Cancer - A First Preliminary Study. Transl Oncol 2017;10:911-6. [PMID: 28987630 DOI: 10.1016/j.tranon.2017.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
12 Bove A, Panaccio P, Palone G, Esposito L, Marino L, Bongarzoni G. Impact of the new guidelines of the American Thyroid Association on the treatment of the differentiated thyroid tumor in an Italian center with medium-high volume thyroid surgery. BMC Surg 2019;18:127. [PMID: 31074397 DOI: 10.1186/s12893-018-0462-8] [Reference Citation Analysis]
13 Colonna M, Borson-Chazot F, Delafosse P, Schvartz C, Guizard AV; FRANCIM network. Progression of incidence and estimate of net survival from papillary thyroid cancers diagnosed between 2008 and 2016 in France. Ann Endocrinol (Paris) 2020;81:530-8. [PMID: 33290751 DOI: 10.1016/j.ando.2020.11.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Panato C, Serraino D, De Santis E, Forgiarini O, Angelin T, Bidoli E, Zanier L, Del Zotto S, Vaccarella S, Franceschi S, Dal Maso L. Thyroid cancer in Friuli Venezia Giulia, northeastern Italy: incidence, overdiagnosis, and impact of type of surgery on survival. Tumori 2019;105:296-303. [PMID: 30917766 DOI: 10.1177/0300891619839307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Koen K, Robin P, Eline N. CHEK2 mutations and papillary thyroid cancer: correlation or coincidence? Hered Cancer Clin Pract 2022;20:5. [PMID: 35101071 DOI: 10.1186/s13053-022-00211-7] [Reference Citation Analysis]
16 Bernasconi A, Barigelletti G, Tittarelli A, Botta L, Gatta G, Tagliabue G, Contiero P, Guzzinati S, Andreano A, Manneschi G, Falcini F, Castaing M, Filiberti RA, Gasparotti C, Cirilli C, Mazzucco W, Mangone L, Iacovacci S, Vitale MF, Stracci F, Piffer S, Tumino R, Carone S, Sampietro G, Melcarne A, Ballotari P, Boschetti L, Pisani S, Cavalieri D'Oro L, Cuccaro F, D'Argenzio A, D'Orsi G, Fanetti AC, Ardizzone A, Candela G, Savoia F, Pascucci C, Castelli M, Storchi C, Trama A. Adolescent and Young Adult Cancer Survivors: Design and Characteristics of the First Nationwide Population-Based Cohort in Italy. J Adolesc Young Adult Oncol 2020;9:586-93. [PMID: 32283044 DOI: 10.1089/jayao.2019.0170] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jeon MJ, Kim HK, Kim EH, Kim ES, Yi HS, Kim TY, Kang HC, Shong YK, Kim WB, Kim BH, Kim WG. Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study. Thyroid 2018;28:1121-7. [PMID: 29897005 DOI: 10.1089/thy.2018.0159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Ramezani M, Saeidi M, Zarei A, Hasani M. Investigating the demographic characteristics and pathological manifestations of thyroid Cancer during the last two decades (1997-2017) in patients referred to Baqiyatallah hospital, Tehran, Iran. J Diabetes Metab Disord 2020;19:1165-72. [PMID: 33553021 DOI: 10.1007/s40200-020-00617-x] [Reference Citation Analysis]
19 Gu J, Zhu J, Qiu Q, Wang Y, Bai T, Yin Y. Prediction of Immunohistochemistry of Suspected Thyroid Nodules by Use of Machine Learning-Based Radiomics. AJR Am J Roentgenol 2019;213:1348-57. [PMID: 31461321 DOI: 10.2214/AJR.19.21626] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
20 Laetitia G, Sven S, Fabrice J. Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses. Cells 2020;9:E830. [PMID: 32235612 DOI: 10.3390/cells9040830] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Boukheris H, Bettayeb A, Anderson LA, Achour Z, Benbachir FZ, Attar S, Saim H, Rouigeb K, Berber N. Changes in the Demographic and Clinicopathological Characteristics of Thyroid Cancer: A Population-Based Investigation in Algeria, 1993-2013. J Cancer Epidemiol 2020;2020:7812791. [PMID: 33029144 DOI: 10.1155/2020/7812791] [Reference Citation Analysis]
22 Kibbelaar RE, Oortgiesen BE, van der Wal-Oost AM, Boslooper K, Coebergh JW, Veeger NJGM, Joosten P, Storm H, van Roon EN, Hoogendoorn M. Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology. Eur J Cancer 2017;86:178-85. [PMID: 28992561 DOI: 10.1016/j.ejca.2017.09.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
23 Dabelić N, Jukić T, Fröbe A. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment. Acta Clin Croat 2020;59:50-9. [PMID: 34219884 DOI: 10.20471/acc.2020.59.s1.06] [Reference Citation Analysis]
24 Lee YM, Jeon MJ, Kim WW, Chung KW, Baek JH, Shong YK, Sung TY, Hong SJ. Comparison Between Familial and Sporadic Non-medullary Thyroid Carcinoma: A Retrospective Individual Risk Factor-Matched Cohort Study. Ann Surg Oncol 2021;28:1722-30. [PMID: 32803550 DOI: 10.1245/s10434-020-09025-0] [Reference Citation Analysis]
25 Dal Maso L, Panato C, Franceschi S, Serraino D, Buzzoni C, Busco S, Ferretti S, Torrisi A, Falcini F, Zorzi M, Cirilli C, Mazzucco W, Magoni M, Collarile P, Pannozzo F, Caiazzo AL, Russo AG, Gili A, Caldarella A, Zanetti R, Michiara M, Mangone L, Filiberti RA, Fusco M, Gasparini F, Tagliabue G, Cesaraccio R, Tumino R, Gatti L, Tisano F, Piffer S, Sini GM, Mazzoleni G, Rosso S, Fanetti AC, Vaccarella S, Fedeli U, Varvarà M, Ravaioli A, Pennelli G, Valla K, Cusimano R, Gasparotti C, Taborelli M, Iannelli A, Leite S, Manneschi G, Patriarca S, Sgargi P, Vicentini M, Puppo A, Vitale MF, Barigelletti G, Pirino DR, Spata E, Ricci P, Madeddu A, Rizzello R, Usala M, Bulatko A, Vercellino PC, Cometti I, Cuccaro F, Sampietro G, Scalzi S, Gola G, Guarda L, Melcarne A, d'Oro LC, Borciani E, Carone S, Candela G, Stoppa G. The impact of overdiagnosis on thyroid cancer epidemic in Italy,1998–2012. European Journal of Cancer 2018;94:6-15. [DOI: 10.1016/j.ejca.2018.01.083] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
26 Oliinyk D, Augustin T, Koehler VF, Rauch J, Belka C, Spitzweg C, Käsmann L. Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis. Cancers (Basel) 2020;12:E2506. [PMID: 32899355 DOI: 10.3390/cancers12092506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wächter S, Vorländer C, Schabram J, Mintziras I, Fülber I, Manoharan J, Holzer K, Bartsch DK, Maurer E. Anaplastic thyroid carcinoma: changing trends of treatment strategies and associated overall survival. Eur Arch Otorhinolaryngol 2020;277:1507-14. [PMID: 32060602 DOI: 10.1007/s00405-020-05853-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Jimenez Londoño GA, Garcia Vicente AM, Sastre Marcos J, Pena Pardo FJ, Amo-Salas M, Moreno Caballero M, Talavera Rubio MP, Gonzalez Garcia B, Disotuar Ruiz ND, Soriano Castrejón AM. Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer. Eur Thyroid J 2018;7:218-24. [PMID: 30283741 DOI: 10.1159/000489850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
29 Dong W, Horiuchi K, Tokumitsu H, Sakamoto A, Noguchi E, Ueda Y, Okamoto T. Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up. Thyroid 2019;29:802-8. [PMID: 30931815 DOI: 10.1089/thy.2018.0128] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
30 Kim M, Han M, Jeon MJ, Kim WG, Kim IJ, Ryu JS, Kim WB, Shong YK, Kim TY, Kim BH. Impact of delayed radioiodine therapy in intermediate-/high-risk papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2019;91:449-55. [PMID: 31102417 DOI: 10.1111/cen.14039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Jukić T, Blažeković I, Franceschi M, Ovčariček PP, Butković MB, Dabelić N, Granić R, Punda M, Sonicki Z, Vagić D, Fröbe A, Kusić Z. Long-Term Outcome of Differentiated Thyroid Cancer Patients—Fifty Years of Croatian Thyroid Disease Referral Centre Experience. Diagnostics 2022;12:866. [DOI: 10.3390/diagnostics12040866] [Reference Citation Analysis]
32 Lin JD, Kuo SF, Huang BY, Lin SF, Chen ST. The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis. Nucl Med Commun 2018;39:1091-6. [PMID: 30180044 DOI: 10.1097/MNM.0000000000000897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
33 Perros P, Mason D, Pearce M, Pearce SHS, Chandler R, Mallick UK. Differentiated thyroid cancer mortality by disease stage in northern England. Clin Endocrinol (Oxf) 2020;93:61-6. [PMID: 32248544 DOI: 10.1111/cen.14187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lin J, Liou M, Hsu H, Leong K, Chen Y, Wang Y, Hung W, Lee H, Tsai H, Tseng C. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer. Thyroid 2018;28:1479-89. [DOI: 10.1089/thy.2017.0639] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
35 Hugen N, Sloot YJE, Netea-Maier RT, van de Water C, Smit JWA, Nagtegaal ID, van Engen-van Grunsven ICH. Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry. J Clin Endocrinol Metab 2020;105:dgz078. [PMID: 31641763 DOI: 10.1210/clinem/dgz078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
36 Wang L, Sun X, He J, Liu Z. Identification and Validation of Prognostic Related Hallmark ATP-Binding Cassette Transporters Associated With Immune Cell Infiltration Patterns in Thyroid Carcinoma. Front Oncol 2022;12:781686. [DOI: 10.3389/fonc.2022.781686] [Reference Citation Analysis]
37 Póvoa AA, Teixeira E, Bella-Cueto MR, Batista R, Pestana A, Melo M, Alves T, Pinto M, Sobrinho-Simões M, Maciel J, Soares P. Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma. Cancers (Basel) 2021;13:2048. [PMID: 33922635 DOI: 10.3390/cancers13092048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Park J, Kim K, Lim DJ, Bae JS, Kim JS. Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study. Sci Rep 2021;11:14908. [PMID: 34290341 DOI: 10.1038/s41598-021-94461-5] [Reference Citation Analysis]
39 Song Y, Lee HS, Park G, Kang S, Lee JW. Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study. Front Endocrinol 2022;13:893461. [DOI: 10.3389/fendo.2022.893461] [Reference Citation Analysis]
40 Minicozzi P, Walsh PM, Sánchez MJ, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannesen TB, Rossi S, Sant M; EUROCARE-5 Working Group. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis? Eur J Cancer 2018;93:127-37. [PMID: 29518726 DOI: 10.1016/j.ejca.2018.01.084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
41 Dionigi G. Is advocacy for active surveillance over definitive intervention in papillary thyroid microcarcinoma applicable to European patients? Gland Surg 2018;7:242-3. [PMID: 29770318 DOI: 10.21037/gs.2017.12.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]